It was suggested that the lack of complete success was due to the failure of the glycerol–saline technique to protect the corneal endothelium. It was therefore decided to investigate directly ...

Auguste G-Y Chiou, MD, Cornea and Refractive Surgery, Department of Ophthalmology, University of Lausanne, Av de France, 15, 1004 Lausanne, Switzerland. AIMS To report the appearances of iridocorneal ...

Descemet stripping only (DSO) offers a novel approach to FECD management, avoiding donor tissue complications and promoting endothelial restoration. Rho kinase inhibitors, such as ripasudil, may ...

pigment dispersion, corneal endothelial touch, as well as visual symptoms related to optic decentration and tilting. Angle-fixated AC IOLs, aphakic or phakic, can also cause problems if they are ...

an allogeneic cell therapy product candidate for the treatment of corneal edema secondary to corneal endothelial dysfunction. According to the company, AURN001 combines allogeneic human corneal ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

AURN001 is a combination cell therapy product candidate comprised of allogeneic human corneal endothelial cells (neltependocel) and a rho kinase inhibitor (Y-27632). AURN001 is intended to be ...

Lowder et al [11] used a high-speed prototype SDOCT (2000 A-scan/s, 1.3 μm wavelength) to characterize inflammatory and pigmented ... spots attached to the cornea endothelium, and fibrinous ...

viggianii. A. A front view from the cornea side; B. A rear view from the retinal side; C. A side view; D. A rear view of the ommatidia DA; E. A rear view of the ommatidia DA; F. A semi-side view of ...